Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer | BMJ Neurology Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Short report

Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer

Online download statistics by month:

Online download statistics by month: March 2020 to February 2023

	Abstract	Full	Pdf
Mar 2020	46	46	12
Apr 2020	119	119	31
May 2020	106	106	15
Jun 2020	148	148	15
Jul 2020	93	93	11
Aug 2020	81	81	23
Sep 2020	95	95	26
Oct 2020	82	82	25
Nov 2020	72	71	23
Dec 2020	74	74	28
Jan 2021	83	83	20
Feb 2021	75	75	20
Mar 2021	128	128	50
Apr 2021	100	100	53
May 2021	89	89	24
Jun 2021	102	102	21
Jul 2021	102	103	35
Aug 2021	98	98	26
Sep 2021	85	86	20
Oct 2021	57	57	32
Nov 2021	100	100	36
Dec 2021	80	80	11
Jan 2022	48	50	10
Feb 2022	31	33	13
Mar 2022	34	35	14
Apr 2022	29	29	10
May 2022	55	54	17
Jun 2022	38	38	10
Jul 2022	30	30	7
Aug 2022	42	43	16
Sep 2022	43	45	18
Oct 2022	38	38	8
Nov 2022	28	28	7
Dec 2022	27	27	4
Jan 2023	18	20	18
Feb 2023	56	56	8
Total	2532	2542	717